Skip to content

Treatment of Vaginal Candidiasis

Comparison of Nigella sativa versus Clotrimazole in remedy of Vaginal Candidiasis

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014111920001N1
Enrollment
100
Registered
2014-12-30
Start date
2006-06-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vaginal Candidiasis. Candidiasis of vulva and vagina

Interventions

Intervention 1: Intervention group: Nigella sativa suppository, 2%, once a day for a week. Intervention 2: Control group: Clotrimazole suppository, 100 ml, once a day for a week.
Treatment - Drugs
Intervention group: Nigella sativa suppository, 2%, once a day for a week.
Control group: Clotrimazole suppository, 100 ml, once a day for a week.

Sponsors

Vice chancellor for research, Mashhad University of medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 49 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Married women between 18-49 years old; Patients who had a single sexual partner and they themselves were the only sexual partner of their respective spouse; Women who had not used antibiotics, immunosuppressive drugs, or vaginal drugs 14 days before the study; Patients who were not at pregnancy or breast-feeding stage and did not consume alcohol. Exclusion criteria: patients with pregnancy, diabetes and immunodeficiency.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Vaginal wall secretion. Timepoint: In the first visit and 7 to 14 days after first visit. Method of measurement: By using speculum.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNafiseh Saghafi

Ghaem Hospital

Quaem.Medical.Center@mums.ac.ir+98 51 3840 0001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026